Literature DB >> 16752165

Antipsychotic drugs and diabetes--an application of the Austin Bradford Hill criteria.

R I G Holt1, R C Peveler.   

Abstract

There is concern that antipsychotic drugs cause diabetes. Although there has been an explosion in the quantity of literature about this subject, it remains confusing and inconsistent. To assess whether the association between antipsychotic drugs and diabetes is causative, we applied the Austin Bradford Hill criteria to the available evidence. In support of a causative relationship, there is temporality for some cases of diabetes, and there is a biologically plausible explanation. The causative link between antipsychotic drugs and diabetes is coherent with our understanding of diabetes and there are other analogies. However the strength of association is weak, there is lack of consistency or specificity, and there is little evidence to support a biological gradient. We should therefore conclude that the evidence surrounding a causative link between antipsychotic drugs and diabetes is inconclusive. Moreover, the risk is probably low and the attributable risk of developing diabetes is greater for traditional risk factors such as family history, ethnicity, obesity and ageing than it is for receiving an antipsychotic drug. Consequently, the majority of patients receiving second-generation antipsychotics will not develop diabetes as a result of their medication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16752165     DOI: 10.1007/s00125-006-0279-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  72 in total

1.  Glucose tolerance and serum insulin levels in an animal model of obesity induced by sub-acute or chronic administration of antipsychotic drugs.

Authors:  T Baptista; L Alvarez; A Lacruz; S de Mendoza; L Hernández
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1999-02       Impact factor: 5.067

2.  Olanzapine impairs glycogen synthesis and insulin signaling in L6 skeletal muscle cells.

Authors:  J Engl; M Laimer; A Niederwanger; M Kranebitter; M Starzinger; M T Pedrini; W W Fleischhacker; J R Patsch; C F Ebenbichler
Journal:  Mol Psychiatry       Date:  2005-12       Impact factor: 15.992

3.  Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs.

Authors:  Marilyn Ader; Stella P Kim; Karyn J Catalano; Viorica Ionut; Katrin Hucking; Joyce M Richey; Morvarid Kabir; Richard N Bergman
Journal:  Diabetes       Date:  2005-03       Impact factor: 9.461

4.  Clozapine, risperidone, olanzapine, and conventional antipsychotic drug effects on glucose, lipids, and leptin in schizophrenic patients.

Authors:  Robert C Smith; Jean-Pierre Lindenmayer; Nigel Bark; Jessy Warner-Cohen; Sumathi Vaidhyanathaswamy; Amaresh Khandat
Journal:  Int J Neuropsychopharmacol       Date:  2005-06       Impact factor: 5.176

Review 5.  Frequency of new-onset diabetes mellitus and use of antipsychotic drugs among Central Texas veterans.

Authors:  Jamie C Barner; Jason Worchel; Min Yang
Journal:  Pharmacotherapy       Date:  2004-11       Impact factor: 4.705

6.  Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study.

Authors:  M Lambert; J M Haro; D Novick; E T Edgell; L Kennedy; M Ratcliffe; D Naber
Journal:  Acta Psychiatr Scand       Date:  2005-03       Impact factor: 6.392

7.  Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders.

Authors:  Bruce J Kinon; Christopher J Kaiser; Saeed Ahmed; Matthew D Rotelli; Sara Kollack-Walker
Journal:  J Clin Psychopharmacol       Date:  2005-06       Impact factor: 3.153

8.  The association of weight gain and olanzapine plasma concentrations.

Authors:  Paul J Perry; Tami R Argo; Ryan M Carnahan; Brian C Lund; Timothy L Holman; Vicki L Ellingrod; Del Miller
Journal:  J Clin Psychopharmacol       Date:  2005-06       Impact factor: 3.153

9.  Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.

Authors:  Douglas L Leslie; Robert A Rosenheck
Journal:  Am J Psychiatry       Date:  2004-09       Impact factor: 18.112

10.  Antipsychotic drugs may worsen metabolic control in type 2 diabetes mellitus.

Authors:  José A Spoelstra; Ronald P Stolk; Dan Cohen; Olav H Klungel; Joëlle A Erkens; Hubertus G M Leufkens; Diederick E Grobbee
Journal:  J Clin Psychiatry       Date:  2004-05       Impact factor: 4.384

View more
  10 in total

1.  Causal criteria and the problem of complex causation.

Authors:  Andrew Ward
Journal:  Med Health Care Philos       Date:  2009-02-14

Review 2.  Diabetes mellitus and severe mental illness: mechanisms and clinical implications.

Authors:  Richard I G Holt; Alex J Mitchell
Journal:  Nat Rev Endocrinol       Date:  2014-12-02       Impact factor: 43.330

Review 3.  Metformin for atypical antipsychotic-induced weight gain and glucose metabolism dysregulation: review of the literature and clinical suggestions.

Authors:  Mehrul Hasnain; W Victor R Vieweg; Sonja K Fredrickson
Journal:  CNS Drugs       Date:  2010-03       Impact factor: 5.749

4.  Metabolic syndrome in people with schizophrenia: a review.

Authors:  Marc DE Hert; Vincent Schreurs; Davy Vancampfort; Ruud VAN Winkel
Journal:  World Psychiatry       Date:  2009-02       Impact factor: 49.548

5.  Dopamine-mediated autocrine inhibitory circuit regulating human insulin secretion in vitro.

Authors:  Norman Simpson; Antonella Maffei; Matthew Freeby; Steven Burroughs; Zachary Freyberg; Jonathan Javitch; Rudolph L Leibel; Paul E Harris
Journal:  Mol Endocrinol       Date:  2012-08-21

6.  Schizophrenia: a multisystem disease?

Authors:  Alex J Mitchell; Timothy G Dinan
Journal:  J Psychopharmacol       Date:  2010-11       Impact factor: 4.153

7.  NIDDK international conference report on diabetes and depression: current understanding and future directions.

Authors:  Richard I G Holt; Mary de Groot; Irwin Lucki; Christine M Hunter; Norman Sartorius; Sherita H Golden
Journal:  Diabetes Care       Date:  2014-08       Impact factor: 19.112

Review 8.  Association Between Antipsychotic Medication Use and Diabetes.

Authors:  Richard I G Holt
Journal:  Curr Diab Rep       Date:  2019-09-02       Impact factor: 4.810

9.  Antipsychotic-Related Risks of Type 2 Diabetes Mellitus in Enrollees With Schizophrenia in the National Basic Public Health Service Program in Hunan Province, China.

Authors:  Feiyun Ouyang; Jun He; Xunjie Cheng; Wei Zhou; Shuiyuan Xiao; Junqun Fang
Journal:  Front Psychiatry       Date:  2022-02-24       Impact factor: 4.157

10.  The role of causal criteria in causal inferences: Bradford Hill's "aspects of association".

Authors:  Andrew C Ward
Journal:  Epidemiol Perspect Innov       Date:  2009-06-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.